{"id":"NCT02038920","sponsor":"Takeda","briefTitle":"Phase III Study of MLN0002 (300 mg) in Treatment of Crohn's Disease","officialTitle":"Phase III, Multicenter, Randomized, Double-blinded, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Intravenous MLN0002 (300 mg) Infusion in Induction and Maintenance Therapy in Japanese Subjects With Moderate or Severe Crohn's Disease","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-01-28","primaryCompletion":"2019-01-25","completion":"2019-05-21","firstPosted":"2014-01-17","resultsPosted":"2019-12-09","lastUpdate":"2019-12-09"},"enrollment":157,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Crohn's Disease"],"interventions":[{"type":"DRUG","name":"Vedolizumab","otherNames":["MLN0002"]},{"type":"DRUG","name":"Vedolizumab placebo","otherNames":[]}],"arms":[{"label":"Induction Phase: Vedolizumab, 300 mg","type":"EXPERIMENTAL"},{"label":"Induction Phase: Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Maintenance Phase: Vedolizumab 300 mg","type":"EXPERIMENTAL"},{"label":"Maintenance Phase: Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Maintenance Phase: Placebo Continuation","type":"PLACEBO_COMPARATOR"},{"label":"Open-Label: Vedolizumab 300 mg","type":"EXPERIMENTAL"}],"summary":"This study is a phase 3, multicenter, randomized, double-blinded, placebo-controlled, parallel-group study to examine the efficacy, safety, and pharmacokinetics of vedolizumab (MLN0002) in induction and maintenance therapy in Japanese participants with moderately or severely active Crohn's disease.","primaryOutcome":{"measure":"Induction Phase: Percentage of Participants With Crohn's Disease Activity Index (CDAI)-100 Response","timeFrame":"Week 10","effectByArm":[{"arm":"Induction Phase: Vedolizumab, 300 mg","deltaMin":26.6,"sd":null},{"arm":"Induction Phase: Placebo","deltaMin":16.7,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.1448"}]},"eligibility":{"minAge":"15 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":56,"countries":["Japan"]},"refs":{"pmids":["32635680"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":8,"n":79},"commonTop":["Nasopharyngitis","Crohn's disease","Pyrexia","Dental caries","Influenza"]}}